News & Updates

Disease flare not uncommon in SLE patients on dialysis
Disease flare not uncommon in SLE patients on dialysis
06 Oct 2022

Nearly one in four patients with systemic lupus erythematosus (SLE) suffer a disease flare during dialysis, with most having haematological manifestations such as thrombocytopaenia, a study has shown.

Disease flare not uncommon in SLE patients on dialysis
06 Oct 2022
Dapagliflozin prevents worsening heart failure, CV death
Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022

Dapagliflozin is a safe treatment to reduce the risk of worsening heart failure (HF) or cardiovascular death both in patients with and without history of recent HF hospitalization, a study has shown.

Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022
Smartphone app fails to boost MVPA in diabetics
Smartphone app fails to boost MVPA in diabetics
06 Oct 2022 byTristan Manalac

Among patients with type 2 diabetes (T2D), use of the smartphone-based app InterWalk does not improve objective measures of moderate-to-vigorous physical activity (MVPA), according to a study.

Smartphone app fails to boost MVPA in diabetics
06 Oct 2022